Just 12 recurrent pathogenic variants have been detected in the PALB2, CHEK2, ATM, RAD51C, RAD51D, and FANCM genes in Finnish BC patients; we have estimated the overall frequency of these variants to be 7.5% in unselected and 13.3% in familial BC patients [25]. This evidence concerns the gene CHEK2 and breast cancer.